Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,371,008
-
Share change
-
+21,222,038
-
Total reported value
-
$793,645,000
-
Price per share
-
$32.75
-
Number of holders
-
39
-
Value change
-
+$690,516,000
-
Number of buys
-
38
Institutional Holders of DICE THERAPEUTICS INC - COM (DICE) as of Q3 2021
As of 30 Sep 2021,
DICE THERAPEUTICS INC - COM (DICE) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,371,008 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Sands Capital Ventures, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, EVENTIDE ASSET MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, Logos Global Management LP, FMR LLC, Soleus Capital Management, L.P., and Avoro Capital Advisors LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.